Weight gain with psychotropic drugs.pptx

Weight gain with
psychotropic drugs
By
Dr Mohammud Ibraheem
Mechanism
1.5HT2A/2C
antagonism
2.Antihistaminic
effects
3.Insulin resistance
Serotonergic Receptors
Serotonin receptors are 7 types, 5-HT1
through 5-HT7. Each type can have
subtypes (A, B, etc.).
They are localized in the brain and in
peripheral organs. The majority of 5-HT
receptors are postsynaptic.
5-HT1A and 5-HT1B are mainly presynaptic
Serotonin receptors are coupled to G
proteins except 5-HT3 receptors which are
ion channel.
Sites of 5-HT2A receptors
5-HT2A receptors are found in::
1. High density in the claustrum
2. Limbic system (amygdala and
hippocampus)
3. The basal ganglia
5HT2A
Agonist Antagonists
1. Efavirenz (an
antiretroviral drug)
2. Lisuride (an
antiparkinson dopamine
agonist)
3. Mefloquine (an
antimalarial drug)
4. lorcaserin
5. lumateperone
1. Trazodone
2. Tricyclic antidepressants:
Amitriptyline, Nortriptyline,
Amoxapine, Clomipramine,
Doxepin, Maprotiline, Imipramine
3. Tetracyclic antidepressants:
Mianserin, Mirtazapine
4. Ketanserin
5. Antipsychotics ; Cariprazine,
clozapine, olanzapine, quetiapine,
risperidone, brexpiprazole,
asenapine, haloperidol and
chlorpromazine
6. Cyproheptadine
Sites of 5HT2C receptors
5HT2C receptors are expressed in:
1) The nucleus accumbens
2) Caudate putamen
3) Olfactory tubercle
4) Claustrum, cingular cortex, amygdala
5) Dentate gyrus, periaqueductal gray,
entorhinal cortex, some brainstem motor
nuclei
5HT2C
Agonists Antagonists
1. Fenfluramine (Dravet
syndrome and Lennox–
Gastaut syndrome)
2. Lorcaserin
3. Arpiprazole ( partial
agonist)
1. Agomelatine
2. Flibanserin (pre-
menopausal hypoactive
sexual desire disorder)
3. Fluoxetine
4. Mirtazapine
5. Trazodone
H1 antagonisms
a) Tricyclic antidepressants;; DOXEPIN the
most potent antihistaminic, the second
potent is amitrptalin, the less potent is
desipramine.
b) Mirtazepine
c) Mianserin
d) Antipsychotics; Ziprasidone, risperidone,
olanzapine, clonzapine, iloperidone and
cariprazine
Insulin resistance
I. Antipsychotics; olanzapine, clozapine,
risperidone, qutiapine, ziprasidone,
arpiprazole
II. Mood stabilizers; valporic acide
Low potency antipsychotics
(chlorpromazine and
thioridazine) produce more
weight gain and sedation
than high potency agents
(haloperidol and
fluphenazine).
Mean weight increases during the first year
of therapy
1. 12 to 14lb for clozapine (5 to 6 kg)
2. 15 to 26lb for olanzapine (7 to 12kg)
3. 6 to 12lb for quetiapine (2.5 to 5kg)
4. Up to 5lb for risperidone (2 to 2.5kg)
5. Less than 2lb for Ziprasidone and
aripiprazole
Thank you
1 sur 12

Contenu connexe

Similaire à Weight gain with psychotropic drugs.pptx

AutocoidsAutocoids
AutocoidsSujit Karpe
6.7K vues49 diapositives
AutocoidsAutocoids
AutocoidsRavish Yadav
1.1K vues74 diapositives
Serotonergic system raviSerotonergic system ravi
Serotonergic system raviPrashant Mishra
4.8K vues58 diapositives

Similaire à Weight gain with psychotropic drugs.pptx(20)

Serotonin & Their antagonistsSerotonin & Their antagonists
Serotonin & Their antagonists
RAJNEESH KUMAR SINGH18.6K vues
5-Hydroxytrptamine & it's Antagonist5-Hydroxytrptamine & it's Antagonist
5-Hydroxytrptamine & it's Antagonist
Shubham Patil17.3K vues
AutocoidsAutocoids
Autocoids
Sujit Karpe6.7K vues
5-Hydroxytyptamine (Serotonin)5-Hydroxytyptamine (Serotonin)
5-Hydroxytyptamine (Serotonin)
Ibrahim Hussein12.7K vues
AutocoidsAutocoids
Autocoids
Ravish Yadav1.1K vues
Serotonergic system raviSerotonergic system ravi
Serotonergic system ravi
Prashant Mishra4.8K vues
Serotonin receptorsSerotonin receptors
Serotonin receptors
FarazaJaved31.8K vues
Serotonin  pharmacologySerotonin  pharmacology
Serotonin pharmacology
AliLaith52304.7K vues
histamin (1).pptxhistamin (1).pptx
histamin (1).pptx
myLord36 vues
Neurohumoral transmission in CNSNeurohumoral transmission in CNS
Neurohumoral transmission in CNS
Sanchit Dhankhar15.4K vues
5-HT Pharmacology - drdhriti5-HT Pharmacology - drdhriti
5-HT Pharmacology - drdhriti
http://neigrihms.gov.in/55K vues
Serotonin Serotonin
Serotonin
Tehran University of Medical Sciences37.8K vues
Serotonin and migraineSerotonin and migraine
Serotonin and migraine
Ankita Bist71 vues
Antidepressants.pptxAntidepressants.pptx
Antidepressants.pptx
FAZAIA RUTH PFAU MEDICAL COLLEGE ,KARACHI,PAKISTAN13 vues

Plus de MohamadAlhes

Fabry disease.pptxFabry disease.pptx
Fabry disease.pptxMohamadAlhes
200 vues43 diapositives
Diagnosing Secondary.pptxDiagnosing Secondary.pptx
Diagnosing Secondary.pptxMohamadAlhes
105 vues46 diapositives
Natalizumab.pptxNatalizumab.pptx
Natalizumab.pptxMohamadAlhes
255 vues27 diapositives

Plus de MohamadAlhes(9)

Fabry disease.pptxFabry disease.pptx
Fabry disease.pptx
MohamadAlhes200 vues
Diagnosing Secondary.pptxDiagnosing Secondary.pptx
Diagnosing Secondary.pptx
MohamadAlhes105 vues
Natalizumab.pptxNatalizumab.pptx
Natalizumab.pptx
MohamadAlhes255 vues
Middle Cerebral Artery SyndromesMiddle Cerebral Artery Syndromes
Middle Cerebral Artery Syndromes
MohamadAlhes16 vues
Serotonin syndromSerotonin syndrom
Serotonin syndrom
MohamadAlhes24 vues
Myasthenia gravis.Myasthenia gravis.
Myasthenia gravis.
MohamadAlhes311 vues

Dernier(20)

MEDICAL RESEARCH.pptxMEDICAL RESEARCH.pptx
MEDICAL RESEARCH.pptx
rishi278942 vues
Pathogenesis of Cell Injury.pptxPathogenesis of Cell Injury.pptx
Pathogenesis of Cell Injury.pptx
Systematic Learning53 vues
NMP-6.pptxNMP-6.pptx
NMP-6.pptx
Sai Sailesh Kumar Goothy41 vues
Biopharmaceutics.pptxBiopharmaceutics.pptx
Biopharmaceutics.pptx
TsegayeNigussie511 vues
Depression PPT templateDepression PPT template
Depression PPT template
EmanMegahed618 vues
NMP-4.pptxNMP-4.pptx
NMP-4.pptx
Sai Sailesh Kumar Goothy32 vues
NMP-5.pptxNMP-5.pptx
NMP-5.pptx
Sai Sailesh Kumar Goothy21 vues
INDIAN SYSTEM OF MEDICINE, UNIT1, MPHARM PCG SEM2.pptxINDIAN SYSTEM OF MEDICINE, UNIT1, MPHARM PCG SEM2.pptx
INDIAN SYSTEM OF MEDICINE, UNIT1, MPHARM PCG SEM2.pptx
Prithivirajan Senthilkumar15 vues
Cholera Romy W. (3).pptxCholera Romy W. (3).pptx
Cholera Romy W. (3).pptx
rweth61318 vues
 CAPSULE CAPSULE
CAPSULE
Ganapathi Vankudoth60 vues
Classification of Cephalosporins.docxClassification of Cephalosporins.docx
Classification of Cephalosporins.docx
Dr. Ajmer Singh Grewal28 vues

Weight gain with psychotropic drugs.pptx

  • 1. Weight gain with psychotropic drugs By Dr Mohammud Ibraheem
  • 3. Serotonergic Receptors Serotonin receptors are 7 types, 5-HT1 through 5-HT7. Each type can have subtypes (A, B, etc.). They are localized in the brain and in peripheral organs. The majority of 5-HT receptors are postsynaptic. 5-HT1A and 5-HT1B are mainly presynaptic Serotonin receptors are coupled to G proteins except 5-HT3 receptors which are ion channel.
  • 4. Sites of 5-HT2A receptors 5-HT2A receptors are found in:: 1. High density in the claustrum 2. Limbic system (amygdala and hippocampus) 3. The basal ganglia
  • 5. 5HT2A Agonist Antagonists 1. Efavirenz (an antiretroviral drug) 2. Lisuride (an antiparkinson dopamine agonist) 3. Mefloquine (an antimalarial drug) 4. lorcaserin 5. lumateperone 1. Trazodone 2. Tricyclic antidepressants: Amitriptyline, Nortriptyline, Amoxapine, Clomipramine, Doxepin, Maprotiline, Imipramine 3. Tetracyclic antidepressants: Mianserin, Mirtazapine 4. Ketanserin 5. Antipsychotics ; Cariprazine, clozapine, olanzapine, quetiapine, risperidone, brexpiprazole, asenapine, haloperidol and chlorpromazine 6. Cyproheptadine
  • 6. Sites of 5HT2C receptors 5HT2C receptors are expressed in: 1) The nucleus accumbens 2) Caudate putamen 3) Olfactory tubercle 4) Claustrum, cingular cortex, amygdala 5) Dentate gyrus, periaqueductal gray, entorhinal cortex, some brainstem motor nuclei
  • 7. 5HT2C Agonists Antagonists 1. Fenfluramine (Dravet syndrome and Lennox– Gastaut syndrome) 2. Lorcaserin 3. Arpiprazole ( partial agonist) 1. Agomelatine 2. Flibanserin (pre- menopausal hypoactive sexual desire disorder) 3. Fluoxetine 4. Mirtazapine 5. Trazodone
  • 8. H1 antagonisms a) Tricyclic antidepressants;; DOXEPIN the most potent antihistaminic, the second potent is amitrptalin, the less potent is desipramine. b) Mirtazepine c) Mianserin d) Antipsychotics; Ziprasidone, risperidone, olanzapine, clonzapine, iloperidone and cariprazine
  • 9. Insulin resistance I. Antipsychotics; olanzapine, clozapine, risperidone, qutiapine, ziprasidone, arpiprazole II. Mood stabilizers; valporic acide
  • 10. Low potency antipsychotics (chlorpromazine and thioridazine) produce more weight gain and sedation than high potency agents (haloperidol and fluphenazine).
  • 11. Mean weight increases during the first year of therapy 1. 12 to 14lb for clozapine (5 to 6 kg) 2. 15 to 26lb for olanzapine (7 to 12kg) 3. 6 to 12lb for quetiapine (2.5 to 5kg) 4. Up to 5lb for risperidone (2 to 2.5kg) 5. Less than 2lb for Ziprasidone and aripiprazole